Skip to content

Study on the mechanism of ' Niaosanzhen ' electroacupuncture in the treatment of neurogenic bladder urinary retention after spinal cord injury

Study on the mechanism of ' Niaosanzhen ' electroacupuncture in the treatment of neurogenic bladder urinary retention after spinal cord injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000142
Enrollment
Unknown
Registered
2024-07-30
Start date
2025-04-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurogenic bladder

Interventions

Sham electroacupuncture group:Sham electroacupuncture treatment, once a day, a total of 1 months of treatment.
electroacupuncture group:Electroacupuncture treatment, once a day, a total of 1 months of treatment.
Drug treatment group:Pyridostigmine bromide tablets was given 60mg once a day for a month

Sponsors

Cangzhou Hospital of Integrated Chinese and Western Medicine, Hebei Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)History of spinal trauma, ASIA classification for incomplete spinal cord injury ; (2)Patients with neurogenic bladder who meet the diagnostic criteria of the Chinese Medical Association Urology Branch ( CUA ) (3)Age 18-65 years old, stable vital signs, clear consciousness ; (4)The course of disease was less than 6 months, and the indwelling catheter was removed. (5)Informed of this study and signed a consent form.

Exclusion criteria

Exclusion criteria: (1)Cognitive impairment, speech disorders ; (2)Severe urinary tract injury, recurrent urinary tract infection, autonomic hyperreflexia ; (3)Severe benign prostatic hyperplasia, urogenital system tumors, severe urethral stricture ; (4)Patients who had undergone genitourinary system surgery or sacral nerve electrical stimulation ; (5)Patients with coagulation disorders or severe heart, liver and kidney dysfunction ; (6)Pregnant or lactating women ; (7)Allergic to Bromobisdamine Tablets ; (8)Fear of acupuncture or intolerance of electroacupuncture ; (9)Participants in other subjects.

Design outcomes

Primary

MeasureTime frame
I-QOL;Urine flow dynamics index;

Secondary

MeasureTime frame
Voiding diary;neurogenic bladder symptom score;

Countries

China

Contacts

Public ContactXueqian Wang

Hebei Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine

820344627@qq.com+86 173 3370 1569

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026